GlassScriptPhysician profile
Melissa Buell
NPI 1750713491
$8,793.36
in general payments reported to CMS, 2019-2025
44 companies · $1,753 in 2025
The $1,753 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,073 · 2022: $1,802 · 2023: $1,433 · 2024: $1,733 · 2025: $1,753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,918.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,033.80 | 2021-2025 | Freestyle Libre 3, Thoratec Heartmate 3 Lvas Implant Kit, Prodigy |
| Novo Nordisk INC | $1,141.05 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $839.25 | 2021-2025 | Evenity, Repatha, Otezla |
| Lilly USA, LLC | $587.05 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $478.50 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $442.39 | 2021-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $355.34 | 2021-2025 | |
| Optinose US, INC. | $303.71 | 2021-2024 | |
| Glaxosmithkline, LLC. | $302.15 | 2021-2025 | Arexvy, Shingrix, Fluarix Quadrivalent |
| Astrazeneca Pharmaceuticals LP | $165.39 | 2021-2024 | Evusheld, Airsupra |
| Pfizer INC. | $147.37 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $147.25 | 2021-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Eisai INC. | $144.11 | 2021-2022 | |
| Corcept Therapeutics | $135.27 | 2025 | Korlym |
| Renalytix Ai, INC. | $121.03 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Buell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.